Search research articles
Contact Us
Filters
Showing results (81-90 of 167) with videos related to
Page
of 17
Sort By:
Cancer Research Communications
|
May 8, 2024
Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer
Naryan Rustgi, Sharon Wu, Timothy Samec, et al.
The Oncologist
|
February 3, 2024
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review
Deniz Can Guven, Gozde Kavgaci, Enes Erul, et al.
BMC Cancer
|
June 5, 2020
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review
Ghulam Rehman Mohyuddin, Muhammad Aziz, Alec Britt, et al.
Expert Opinion on Biological Therapy
|
June 15, 2023
The role of immune checkpoint inhibitors for patients with advanced stage microsatellite stable colorectal cancer and high tumor mutation burden: quantity or quality?
Charan Thej Reddy Vegivinti, Cyndi Gonzales Gomez, Masood Syed, et al.
Journal of Healthcare Engineering
|
June 9, 2020
Cloud-Based Breast Cancer Prediction Empowered with Soft Computing Approaches
Farrukh Khan, Muhammad Adnan Khan, Sagheer Abbas, et al.
BMC Cancer
|
July 2, 2025
Neoadjuvant chemoradiotherapy with or without PD-1/PD-L1 inhibitors in locally advanced rectal cancer: a systematic review and meta-analysis
Muhammad Ansab, Sepideh Razi, Farwa Nisa, et al.
Plos One
|
April 15, 2025
The role of ANGPTL4 in cancer: A meta-analysis of observational studies and multi-omics investigation
Osama M Younis, Abdalrahman S Dhaydel, Wasfi F Alghwyeen, et al.
Cancers
|
July 15, 2026
A Clinical and Molecular Comparative Analysis of KRAS Exon 2 and KRAS Non-Exon 2 Mutated Colorectal Cancer
Doga Kahramangil Baytar, Paola Zinser-Peniche, Shuaichao Wang, et al.
American Journal of Clinical Oncology
|
November 17, 2016
Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer
Rangaswamy Govindarajan, Swetha Gujja, Eric R Siegel, et al.
Exploration of Targeted Anti-Tumor Therapy
|
July 17, 2023
Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy
Stijn Hentzen, Kathan Mehta, Raed Moh'd Taiseer Al-Rajabi, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 167) with videos related to
Sort By:
Page
of 17
Cancer Research Communications
|
May 8, 2024
Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer
Naryan Rustgi, Sharon Wu, Timothy Samec, et al.
The Oncologist
|
February 3, 2024
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review
Deniz Can Guven, Gozde Kavgaci, Enes Erul, et al.
BMC Cancer
|
June 5, 2020
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review
Ghulam Rehman Mohyuddin, Muhammad Aziz, Alec Britt, et al.
Expert Opinion on Biological Therapy
|
June 15, 2023
The role of immune checkpoint inhibitors for patients with advanced stage microsatellite stable colorectal cancer and high tumor mutation burden: quantity or quality?
Charan Thej Reddy Vegivinti, Cyndi Gonzales Gomez, Masood Syed, et al.
Journal of Healthcare Engineering
|
June 9, 2020
Cloud-Based Breast Cancer Prediction Empowered with Soft Computing Approaches
Farrukh Khan, Muhammad Adnan Khan, Sagheer Abbas, et al.
BMC Cancer
|
July 2, 2025
Neoadjuvant chemoradiotherapy with or without PD-1/PD-L1 inhibitors in locally advanced rectal cancer: a systematic review and meta-analysis
Muhammad Ansab, Sepideh Razi, Farwa Nisa, et al.
Plos One
|
April 15, 2025
The role of ANGPTL4 in cancer: A meta-analysis of observational studies and multi-omics investigation
Osama M Younis, Abdalrahman S Dhaydel, Wasfi F Alghwyeen, et al.
Cancers
|
July 15, 2026
A Clinical and Molecular Comparative Analysis of KRAS Exon 2 and KRAS Non-Exon 2 Mutated Colorectal Cancer
Doga Kahramangil Baytar, Paola Zinser-Peniche, Shuaichao Wang, et al.
American Journal of Clinical Oncology
|
November 17, 2016
Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer
Rangaswamy Govindarajan, Swetha Gujja, Eric R Siegel, et al.
Exploration of Targeted Anti-Tumor Therapy
|
July 17, 2023
Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy
Stijn Hentzen, Kathan Mehta, Raed Moh'd Taiseer Al-Rajabi, et al.
Page
of 17